{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:17:25Z","timestamp":1784297845778,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"am","delay-in-days":368,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["23fk0108682s0501"],"award-info":[{"award-number":["23fk0108682s0501"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20KK0152"],"award-info":[{"award-number":["20KK0152"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.vaccine.2024.02.062","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T21:33:08Z","timestamp":1709242388000},"page":"2299-2309","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Protective efficacy of recombinant Toxoplasma gondii dense granule protein 15 against toxoplasmosis in C57BL\/6 mice"],"prefix":"10.1016","volume":"42","author":[{"given":"Tanjila","family":"Hasan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Shimoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Bzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5603-1669","authenticated-orcid":false,"given":"Nanako","family":"Ushio-Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5005-6377","authenticated-orcid":false,"given":"Yoshifumi","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.02.062_b0005","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2024.02.062_b0010","series-title":"Toxoplasmosis of animals and humans","first-page":"336","author":"Dubey","year":"2010"},{"key":"10.1016\/j.vaccine.2024.02.062_b0015","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1128\/CMR.05013-11","article-title":"Epidemiology of and diagnostic strategies for toxoplasmosis","volume":"25","author":"Robert-Gangneux","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2024.02.062_b0020","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ijpara.2009.02.004","article-title":"Toxoplasmosis: a history of clinical observations","volume":"39","author":"Weiss","year":"2009","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2024.02.062_b0025","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.4315\/0362-028X.JFP-11-418","article-title":"Ranking the disease burden of 14 pathogens in food sources in the United States using attribution data from outbreak investigations and expert elicitation","volume":"75","author":"Batz","year":"2012","journal-title":"J Food Prot"},{"key":"10.1016\/j.vaccine.2024.02.062_b0030","first-page":"286","article-title":"Economic and public health importance of Toxoplasma gondii infections in sheep: 2009-2020","author":"Dubey","year":"2020","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2024.02.062_b0035","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.rvsc.2020.06.014","article-title":"Public health and economic importance of Toxoplasma gondii infections in goats: the last decade","volume":"132","author":"Dubey","year":"2020","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2024.02.062_b0040","volume":"31","author":"Dunay","year":"2018","journal-title":"Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice"},{"key":"10.1016\/j.vaccine.2024.02.062_b0045","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2147\/DDDT.S60973","article-title":"Drugs in development for toxoplasmosis: advances, challenges, and current status","volume":"11","author":"Alday","year":"2017","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.vaccine.2024.02.062_b0050","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1017\/S003118200000144X","article-title":"A commercial vaccine for ovine toxoplasmosis","volume":"110","author":"Buxton","year":"1995","journal-title":"Parasitology"},{"key":"10.1016\/j.vaccine.2024.02.062_b0055","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/14712598.2018.1413086","article-title":"Moving towards improved vaccines for Toxoplasma gondii","volume":"18","author":"Li","year":"2018","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.vaccine.2024.02.062_b0060","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/infdis\/172.6.1561","article-title":"Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease","volume":"172","author":"Howe","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.02.062_b0065","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1128\/CMR.00005-17","article-title":"Toxoplasma effectors targeting host signaling and transcription","volume":"30","author":"Hakimi","year":"2017","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2024.02.062_b0070","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1084\/jem.20100717","article-title":"Strain-specific activation of the NF-\u03baB pathway by GRA15, a novel Toxoplasma gondii dense granule protein","volume":"208","author":"Rosowski","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2024.02.062_b0075","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.3389\/fimmu.2020.01709","article-title":"Toxoplasma gondii dense granule proteins 7, 14, and 15 are involved in modification and control of the immune response mediated via NF-\u03baB pathway","volume":"11","author":"Ihara","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.02.062_b0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051448","article-title":"Toxoplasma gondii clonal strains all inhibit STAT1 transcriptional activity but polymorphic effectors differentially modulate IFN-\u03b3 induced gene expression and STAT1 phosphorylation","volume":"7","author":"Rosowski","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.02.062_b0085","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019103758","article-title":"Toxoplasma GRA15 limits parasite growth in IFN \u03b3-activated fibroblasts through TRAF ubiquitin ligases","volume":"39","author":"Mukhopadhyay","year":"2020","journal-title":"EMBO J"},{"key":"10.1016\/j.vaccine.2024.02.062_b0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/vaccines10010021","article-title":"Toxoplasma gondii GRA15 DNA vaccine with a liposomal nanocarrier composed of an ss-cleavable and pH-activated lipid-like material induces protective immunity against toxoplasmosis in mice","volume":"10","author":"Hasan","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2024.02.062_b0095","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1586\/14760584.2015.1011133","article-title":"DNA vaccination with genes encoding Toxoplasma gondii antigens ROP5 and GRA15 induces protective immunity against toxoplasmosis in Kunming mice","volume":"14","author":"Chen","year":"2015","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2024.02.062_b0100","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1128\/EC.00297-10","article-title":"Type II Toxoplasma gondii KU80 knockout strains enable functional analysis of genes required for cyst development and latent infection","volume":"10","author":"Fox","year":"2011","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.vaccine.2024.02.062_b0105","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1128\/IAI.00782-08","article-title":"Intervacuolar transport and unique topology of GRA14, a novel dense granule protein in Toxoplasma gondii","volume":"76","author":"Rome","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2024.02.062_b0110","doi-asserted-by":"crossref","unstructured":"Sangar\u00e9 LO, Yang N, Konstantinou EK, Lu D, Mukhopadhyay D, Young LH, et al. Toxoplasma GRA15 activates the NF-\u03baB pathway through interactions with TNF receptor-associated factors. MBio 2019;10. https:\/\/doi.org\/10.1128\/mbio.00808-19.","DOI":"10.1128\/mBio.00808-19"},{"key":"10.1016\/j.vaccine.2024.02.062_b0115","doi-asserted-by":"crossref","unstructured":"Fereig RM, Kuroda Y, Terkawi MA, Mahmoud ME, Nishikawa Y. Immunization with Toxoplasma gondii peroxiredoxin 1 induces protective immunity against toxoplasmosis in mice. PLoS One 2017;12. https:\/\/doi.org\/10.1371\/journal.pone.0176324.","DOI":"10.1371\/journal.pone.0176324"},{"key":"10.1016\/j.vaccine.2024.02.062_b0120","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/CVI.00747-12","article-title":"Development of an immunochromatographic assay based on dense granule protein 7 for serological detection of Toxoplasma gondii infection","volume":"20","author":"Terkawi","year":"2013","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2024.02.062_b0125","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1128\/CVI.00032-09","article-title":"Immunization with oligomannose-coated liposome-entrapped dense granule protein 7 protects dams and offspring from Neospora caninum infection in mice","volume":"16","author":"Nishikawa","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2024.02.062_b0130","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1128\/IAI.00439-13","article-title":"Transcriptome analysis of mouse brain infected with Toxoplasma gondii","volume":"81","author":"Tanaka","year":"2013","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2024.02.062_b0135","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00281-012-0339-3","article-title":"Immune response and immunopathology during toxoplasmosis","volume":"34","author":"Dupont","year":"2012","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.vaccine.2024.02.062_b0140","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(02)01357-5","article-title":"Importance of IgG2c isotype in the immune response to \u03b2-amyloid in amyloid precursor protein\/transgenic mice","volume":"338","author":"Petrushina","year":"2003","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.vaccine.2024.02.062_b0145","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nrmicro2858","article-title":"Modulation of innate immunity by Toxoplasma gondii virulence effectors","volume":"10","author":"Hunter","year":"2012","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2024.02.062_b0150","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1385\/IR:27:2-3:521","article-title":"Induction and regulation of IL-12-dependent host resistance to toxoplasma gondii","volume":"27","author":"Sher","year":"2003","journal-title":"Immunol Res"},{"key":"10.1016\/j.vaccine.2024.02.062_b0155","doi-asserted-by":"crossref","unstructured":"Snyder LM, Doherty CM, Mercer HL, Denkers EY. Induction of IL-12p40 and type 1 immunity by Toxoplasma gondii in the absence of the TLRMyD88 signaling cascade. PLoS Pathog 2021;17. https:\/\/doi.org\/10.1371\/journal.ppat.1009970.","DOI":"10.1371\/journal.ppat.1009970"},{"key":"10.1016\/j.vaccine.2024.02.062_b0160","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.4049\/jimmunol.177.4.2584","article-title":"Toxoplasma gondii genotype determines MyD88-dependent signaling in infected macrophages","volume":"177","author":"Kim","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2024.02.062_b0165","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.parint.2016.09.008","article-title":"Peroxiredoxin 3 promotes IL-12 production from macrophages and partially protects mice against infection with Toxoplasma gondii","volume":"65","author":"Fereig","year":"2016","journal-title":"Parasitol Int"},{"key":"10.1016\/j.vaccine.2024.02.062_b0170","doi-asserted-by":"crossref","first-page":"13955","DOI":"10.1073\/pnas.94.25.13955","article-title":"A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice","volume":"94","author":"Khan","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2024.02.062_b0175","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/pim.12113","article-title":"Protection and pathology during parasite infection: IL-10 strikes the balance","volume":"36","author":"Redpath","year":"2014","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2024.02.062_b0180","article-title":"Protective immunity against Neospora caninum infection induced by 14\u20133-3 protein in mice","volume":"8","author":"Li","year":"2021","journal-title":"Front Vet Sci"},{"key":"10.1016\/j.vaccine.2024.02.062_b0185","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-40147-z","article-title":"Evaluation of long-term immunity and protection against T. gondii after immunization with multivalent recombinant chimeric T. gondii proteins","volume":"13","author":"Chyb","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2024.02.062_b0190","doi-asserted-by":"crossref","unstructured":"Sun HC, Deng PM, Fu Y, Deng JH, Xie RH, Huang J, et al. Protective efficacy of Toxoplasma gondii GRA12 or GRA7 recombinant proteins encapsulated in PLGA nanoparticles against acute Toxoplasma gondii infection in mice. Front Cell Infect Microbiol 2023;13. https:\/\/doi.org\/10.3389\/fcimb.2023.1209755.","DOI":"10.3389\/fcimb.2023.1209755"},{"key":"10.1016\/j.vaccine.2024.02.062_b0195","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/CMR.11.4.569","article-title":"Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection","volume":"11","author":"Denkers","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2024.02.062_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2021.105150","article-title":"Evaluation of Th17 immune responses of recombinant DNA vaccine encoding GRA14 and ROP13 genes against Toxoplasma gondii in BALB\/C mice","volume":"96","author":"Fatollahzadeh","year":"2021","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.vaccine.2024.02.062_b0205","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.pt.2011.08.001","article-title":"Toxoplasma gondii effectors are master regulators of the inflammatory response","volume":"27","author":"Melo","year":"2011","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.vaccine.2024.02.062_b0210","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature05395","article-title":"Toxoplasma co-opts host gene expression by injection of a polymorphic kinase homologue","volume":"445","author":"Saeij","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2024.02.062_b0215","doi-asserted-by":"crossref","first-page":"29366","DOI":"10.1074\/jbc.M111.253435","article-title":"A conserved non-canonical motif in the pseudoactive site of the ROP5 pseudokinase domain mediates its effect on Toxoplasma virulence","volume":"286","author":"Reese","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2024.02.062_b0220","doi-asserted-by":"crossref","first-page":"9625","DOI":"10.1073\/pnas.1015980108","article-title":"Polymorphic family of injected pseudokinases is paramount in Toxoplasma virulence","volume":"108","author":"Reese","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2024.02.062_b0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000576","article-title":"Phosphorylation of mouse immunity-related gtpase (IRG) resistance proteins is an evasion strategy for virulent Toxoplasma gondii","volume":"8","author":"Steinfeldt","year":"2010","journal-title":"PLoS Biol"},{"key":"10.1016\/j.vaccine.2024.02.062_b0230","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s11845-022-02998-9","article-title":"Toxoplasma gondii vaccine candidates: a concise review","volume":"192","author":"Mamaghani","year":"2023","journal-title":"Ir J Med Sci"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24002214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24002214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T19:30:29Z","timestamp":1723059029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24002214"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0264410X24002214"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.02.062","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective efficacy of recombinant Toxoplasma gondii dense granule protein 15 against toxoplasmosis in C57BL\/6 mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.02.062","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}